← SynDRA
VORAPAXAR
SynDRA canonical compound SYN0016089 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | F2R |
|---|
| Mechanism of action | thrombin inhibitor |
|---|
| Indication | myocardial infarction | peripheral artery disease (PAD) |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- F2R ANTAGONIST
- Proteinase-activated receptor 1 antagonist
- thrombin inhibitor
Drug classes
- Hematologic Agents
- Platelet Aggregation Inhibitors
- Protease-activated Receptor-1 Antagonists
- Protease-activated Receptor-1 Antagonist
ATC classes
- B01A · ANTITHROMBOTIC AGENTS
Cross-references
Synonyms
- SCH 530348
- SCH530348
- vorapaxar sulfate
- zontivity
- Zontivity
- SCH-530348
- UNII-ZCE93644N2
- CHEMBL493982
- CHEBI:82702
- ZCE93644N2
- MK-5348
- ethyl ((1R,3aR,4aR,6R,8aR,9S,9aS)-9-((E)-2-(5-(3-fluorophenyl)pyridin-2-yl)vinyl)-1-methyl-3-oxododecahydronaphtho[2,3-c]furan-6-yl)carbamate
- Ethyl [(1r,3ar,4ar,6r,8ar,9s,9as)-9-{(E)-2-[5-(3-Fluorophenyl)pyridin-2-Yl]ethenyl}-1-Methyl-3-Oxododecahydronaphtho[2,3-C]furan-6-Yl]carbamate
- Vorapaxar [USAN:INN]
- Carbamic acid, [(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-fluorophenyl)-2- pyridinyl]etheny
- Sch 530348
- vorapaxarum
- RefChem:56276
- B01AC26
- DTXCID801436165
- Vorapaxar free base
- MFCD16038876
- MK 5348
- Vorapaxar [USAN]
- Vorapaxar?
- C29H33FN2O4
- Vorapaxar [INN]
- an-6-yl]carbamate
- Vorapaxar (Standard)
- VORAPAXAR [MI]
- Vorapaxar (USAN/INN)
- VORAPAXAR [VANDF]
- Vorapaxar (MK-5348)
- VORAPAXAR [MART.]
- VORAPAXAR [WHO-DD]
- MLS006010324
- SCHEMBL471187
- GTPL4047
Reported adverse events
Look up VORAPAXAR in the interactive SynDRA portal →